KERX - Keryx Biopharmaceuticals, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5502.92M
Enterprise Value 3548.7M
Trailing P/E N/A
Forward P/E 1-21.10
PEG Ratio (5 yr expected) 1-0.06
Price/Sales (ttm)8.29
Price/Book (mrq)N/A
Enterprise Value/Revenue 39.05
Enterprise Value/EBITDA 6-5.45

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Dec 31, 2017


Profit Margin -269.52%
Operating Margin (ttm)-167.69%

Management Effectiveness

Return on Assets (ttm)-42.33%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)60.64M
Revenue Per Share (ttm)0.53
Quarterly Revenue Growth (yoy)96.00%
Gross Profit (ttm)35.61M
EBITDA -100.75M
Net Income Avi to Common (ttm)-163.44M
Diluted EPS (ttm)-1.43
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)93.53M
Total Cash Per Share (mrq)0.79
Total Debt (mrq)125M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.12
Book Value Per Share (mrq)-0.12

Cash Flow Statement

Operating Cash Flow (ttm)-93.49M
Levered Free Cash Flow (ttm)-24.91M

Trading Information

Stock Price History

Beta 2.65
52-Week Change 3-26.76%
S&P500 52-Week Change 315.91%
52 Week High 38.38
52 Week Low 34.01
50-Day Moving Average 34.70
200-Day Moving Average 35.44

Share Statistics

Avg Vol (3 month) 31.34M
Avg Vol (10 day) 31.85M
Shares Outstanding 5119.18M
Float 82.5M
% Held by Insiders 11.32%
% Held by Institutions 167.04%
Shares Short 320.25M
Short Ratio 37.76
Short % of Float 325.20%
Shares Short (prior month) 316.71M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A